30 Sep 2026 quarter: consolidated revenue up 93% and profit after tax up 206% year on year
VALIANTORG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.7 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Unaudited consolidated quarter ended 30 September 2026: revenue was Rs 30,421.76 lakh versus Rs 15,730.51 lakh a year earlier, up 93.4%, and profit after tax was Rs 1,729.56 lakh versus Rs 566.19 lakh, up 205.5%. The consolidated half year to 30 September 2026 had revenue Rs 53,575.61 lakh, profit after tax Rs 4,655.89 lakh and operating cash flow of positive Rs 2,284.18 lakh. A related-party manufacturing deal with Aarti Pharma was disclosed.
Revenue and profit growth supports positive sentiment, though after-tax profit fell from the prior quarter and working capital needs are high.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹304.2 Cr | ₹157.3 Cr | +93.4% |
| Operating profit | ₹23.53 Cr | ₹7.16 Cr | +228.6% |
| Profit after tax | ₹17.30 Cr | ₹5.66 Cr | +205.5% |
| EBITDA margin | 12.8% | 13.4% | −0.6 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.